Related Experiment Video
Updated: Sep 26, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Abstract:
The introduction of combined measles, mumps and rubella (MMR) vaccine into the UK childhood immunisation schedule in 1988 has markedly reduced the incidence of these diseases and their complications, with, for example, no deaths from acute measles occurring since 1992. However, uptake of MMR vaccine has fallen since the publication, in 1998, of a study that suggested a link between exposure to the vaccine and the development of intestinal inflammation and autism. The study, and the subsequent debate, have attracted considerable media coverage and left many parents and some healthcare professionals uncertain about what to do. While in 1996, 92% of children in England and Wales had received their first dose of the vaccine by the age of 2 years, by 2001-2 this figure had fallen to 84%, with much lower uptake in some regions, threatening a resurgence of all three diseases. Here, we review the evidence for the effectiveness and safety of MMR vaccine.
Insights
The measles, mumps, and rubella (MMR) vaccine is highly effective and safe, significantly reducing disease incidence. Declining MMR vaccine uptake due to safety concerns threatens a resurgence of these preventable diseases.
Area of Science:
- Immunology
- Public Health
- Pediatrics
Background:
- The combined measles, mumps, and rubella (MMR) vaccine was introduced in the UK in 1988.
- MMR vaccine significantly reduced the incidence of measles, mumps, and rubella and their complications.
- A 1998 study suggesting a link between MMR and autism/intestinal inflammation led to decreased vaccine uptake.
Purpose of the Study:
- To review the evidence for the effectiveness of the MMR vaccine.
- To review the evidence for the safety of the MMR vaccine.
Main Methods:
- Literature review of studies on MMR vaccine effectiveness.
- Literature review of studies on MMR vaccine safety.
Main Results:
- The MMR vaccine has markedly reduced the incidence of measles, mumps, and rubella.
- No deaths from acute measles have occurred in the UK since 1992.
- MMR vaccine uptake in England and Wales fell from 92% in 1996 to 84% in 2001-2.
Conclusions:
- The MMR vaccine is effective in preventing measles, mumps, and rubella.
- Evidence does not support a link between the MMR vaccine and autism or intestinal inflammation.
- Declining vaccination rates pose a risk of disease resurgence.
Related Concept Videos
Vaccines
Vaccinations
Microorganisms in Medicine and Therapeutics
Poliomyelitis
Smallpox
Respiratory Syncytial Virus Disease

